Member Info for Quickdraw18

Would seem it's the Optigene LAMP test, Dr Kidd and Fowler are also running it in the mobile device from a van. There is a nift street view style view of the van and inside. I didn't notice anything in particular.

I've not found anything concrete on Novacyt, thought I landed it with the LAMP recipe but was inconclusive. I'm still back Novacyt are manufacturing. Novacyt staff are still liking posts and it's mostly sales person to date, with Graham in on one post going back a month. Here's the recent team likes, sleep easy:

Liz Ferrera - 10 yrs at comp, sales manager for America
https://www.linkedin.com/posts/kiddstephen_hhft-microbiology-team-on-the-move-the-activity-6689535230451179520-fGg_

Jacob Barratt - 16 months, head UK sales
Liz again
https://www.linkedin.com/posts/activity-6689512100315852800-8CR9

Liz again
https://www.linkedin.com/posts/kiddstephen_nhs-covid-19-lab-in-motion-3d-virtual-tour-activity-6689543624650174464-hDzW

lol Digitt, it was 26th June 2018. Thank you Jack white concert photos for the memory jog and my inappropriate styling lol.

Your doing better than me. Averaging 7p on my main holding, got a chunk under my folks names at lower base. I almost added another mill today but decided against greed and went for a walk with the parents. Hope you had a lovely boozy golfing afternoon. Am already wishing the weekend away lol

Bogyo in the Eli Lilly Covid announcement they state:

"Lilly is researching multiple approaches to treating COVID-19. Existing Lilly medicines are now being studied to understand their potential in treating complications of COVID-19, and the company is collaborating with two biotech companies to discover novel antibody treatments for COVID-19".

If Lilly are "only" using Hemos mice to test COVID I see no reason why they would declare where they source their mice.
It seems reasonable to assume Hemos mice have or will be used to test one or both antibody candidates.

Taking your point about declaring partners in trails Hemo seem unlikely to be heavily involved in LY-CoV555. I'd lean towards involvement in second COVID antibody which appears to be at pre clinical.

Oxford uni vaccine team tested on mice. Normal mice can not be used for COVID, my understanding's mice developed for SARS1 or humanised mice can be used. We have a long standing agreement with oxford and they helped develop Hemo's mice.

I was in that shareholders meeting Digitt looking rather out of place with my shades, crazy cloths and crutches.
To that point I had been sceptical if Vlad as he's a bit wacky on twitter, in the flesh I was impressed by Vlad, found him to be very genuine and passionate about his cause. He defiantly struck me as a scientist rather than business man, I'm fine with this as he has Sir Feldmann creator of worlds best selling drug behind him to guide Vlad and products through to commercialisation and in particular commercial negotiations. I too held off taking a large investment in Hemo until 6 months ago as had been expecting CDX deal in early 2020. I got the jitters with COVID and sold most my shares in feb/ march and since rebought x15 or more in past few months.

As a side note I'd really like to hear from Sir Feldmann at the Q&A. Spurred me into a question lol

high only in past 6 months age I increased holding and by 10 fold since April.

Primer would do well to stay away from UK politics and just offer to increase supply if it's available

Cheers Pingu :-)

Here are questions I'm submiting. Assuming we'll receive CDX update prior to Q&A:

. Have Hemogenyx's ApbHC mice been used or will be used in COVID trails outside of your own projects and Orgenesis?

. Can you provide update on COVID projects and are you working on any T-cell COVID projects?

. Can you provide an update on CDX and clinical trail plans?

. Can you provide an update on Hu-PHEC developments?

. Can you explain the potential of ApbHC platform for discovering new treatments and the interest you have received?

. Could you provide revenue estimate for ApbHC mice sales?

Much appreciation for the person who found the Eli COVID release. Would make sense that Hemos mice were used to test both COVID antibodies plus being used to screen preexisting treatments. Results for the first two specific COVID treatments were due end of June.

Role on CDX deal, surely will land by Monday.

https://investor.lilly.com/news-releases/news-release-details/lilly-begins-worlds-first-study-potential-covid-19-antibody

That was me :-)

Thanks for the shout out MKumar :-) lovely start to the week, topped up £100k at 10p roll on Monday.

Surely we get a an RNS to nudge our questions as they will likely pretty predictable otherwise

Not given them much tought yet. Thinking :

Market extimate for Mice, will these be royalty and revenue revenue receiving
Are they expanding into CAR-T COVID
Are COVID anybody neutralising treatments dead due to short duration of immunity
Hu-PHEC time lies, especially grafting transplant material from the patient
Details on Global Co
Why did J&J development work get assigned to Global go, are they one if same and if nut why did J&J not pursue.
What another immune conditions can antibodies CAR-T attack, have seem HIV mentioed.
What is the DNA match of humanised mice, I'm let to believe 95%
Will humanised mice allow testing to be expedited
Does camp habe plan to sell, conversely does company has plans to fully utilise its drug discovery platform.
Has company been to produce cost benefit model of their mighty mice over minow mice
Will be publicly hearing Sir Marc Feldman share his extensive experience
Time lines for CDX phase 1 to 3 and can 1 and 2 be run in clsoe proximity

Just a brain storm. I'll refine during the week.

Do people want to collate on here to make the session run more smoothly?

I'll work mine better when not about to snooze.

Dibgeel this is it for Hemo. Have eyes on 7,figutes very soon. Though In p aatient enough to hold for a double digit £b valuation

Bought in at, 6 and been 60% down for most of 3 year. Always felt be a golden goose or dead duck, it don't feel quackers lolo
Be buying borrow of champagne which I hate just in case.. Good luck for next week all. Hope you shorts air had time to move along

I'll be here for years to come. Waiting on the next news flow.

Very exciting times Pingu. Totally agree with you, these mice are game changers. Approx 97% of products fail by phase 3. It's a significant percent at phase one. Testing using Hemos mice with 95% humanised mice can revolutionise drug identification, speeding it up, significantly reduce risk of failure and increase number of drug candidates that's can be trialed. Exciting times I do believe :-)

Global Co are obviously happy enough with CDX development to sign a Lupus and platform deal for developing other autoimmune conditions. CDX deal is certainly in the bag. The new agreements are in line with CDX deal which we can assume Vlad is happy with the framework terms they have in place with Global Co.

I've no idea if the mention of peptides broadens Hemos potential portfolio. Any views?

Today's vid. I believe the term is Easter Egg

https://youtu.be/LP95GWupyNA

JHFH my wag is that we will find out Global Co when they sign the CDX deal to go into phase 1 as this will include payments which will be material, plus the trail will need to be logged and partnership announced.

I suspect if we have further success on Lupus, COVID or other autoimmune condition Global Co will take a good look at buying Hemo. My view on buy out have changed today, given Vlads comment on organisational fit.

Big news, if I were short, out or a day trader I would be thanking Vlad today. He's given you an opportunity to rectify your missteps

Personally I'm extremely happy with today's stepping stone, been planning to buy extra 500k but had been waiting to on Novacyt to sales pop. Should get the chance to execute sometime this week and have chance for my investment crew to buy in or top up.

We've got the milk and the oven to bake (mice) now global go are going to supply us with the product ideas, be it chocolate bars, cakes, chocolate drinks, the icing on top. Catch my drift

AML, All, Lupus, COVID, other autoimmune conditions. Let's get baking

CDX
Lupus
Nice used to discover unspecified autoimmune conditions

J&J originally worked on Lupus, but in last RNS the agreement was with Global Co. Now he name checks J&J today, is this too obvious.

Would have been nice to have more meet on the bones. However, this statement does back up how transformational Hemos little mice can be in drug discovery #bloodcancer #autoimmuneconditions #COVID

Webinar 20th 4pm UK time

I'd take a chill buddy, a day or two in science is a drop in the water. I've waitined 18 months for an update on Hemogenyx mice. Patience is rewarded :-)

Wake me up tomorrow lol

https://youtu.be/tc8JnQjSCjQ